Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study"
- PMID: 38606425
- PMCID: PMC11016495
- DOI: 10.3350/cmh.2024.0214
Correspondence on Letter regarding "Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study"
Keywords: Cardiometabolic criteria; Cardiovascular disease; Liver biopsy.
Conflict of interest statement
The authors have no conflicts to disclose.
References
-
- Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, et al. Clinical outcomes in biopsy-proven nonalcoholic fatty liver disease patients: A multicenter registry-based cohort study. Clin Gastroenterol Hepatol. 2023;21:370–379. - PubMed
-
- Arafa A, Kashima R, Matsumoto C, Kokubo Y. Fatty liver index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The suita study. J Stroke Cerebrovasc Dis. 2024;33:107495. - PubMed
-
- Leung JC, Loong TC, Wei JL, Wong GL, Chan AW, Choi PC, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology. 2017;65:54–64. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
